| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.7× | −1.7× | |
| Price / Book | −14.3× | 2.0× | |
| Price / Sales | 10.8× | 3.9× | |
| Price / Free cash flow | −9.1× | −1.5× | |
| EV / EBITDA | −7.4× | −1.2× | |
| Earnings yield | −17.4% | −14.3% | |
| Free cash flow yield | −11.0% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,284.12 | +3.53% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.30 | +2.17% | $624.89B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $289.14 | +2.29% | $510.94B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.44 | +3.33% | $377.38B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.17 | +3.16% | $365.56B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.47 | +2.18% | $282.92B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.58 | +2.82% | $261.45B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $687.45 | +1.19% | $254.18B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $434.97 | +2.36% | $235.16B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.45 | +2.21% | $193.99B | 22.3× | 37.5% | +29.9% |
